Atlas Trials

A Phase II Study of Iressa in Patients With Chemo Refractory Germ Cell Tumors Expressing EGFR

Clinical trial NCT00198159 · TERMINATED

Trial details

NCT number
NCT00198159
Sponsor
Indiana University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Refractory Germ Cell Tumors Expressing EGRF
Start date
2002-09-01
Primary completion
2006-02-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.